pharma

Pharma Holding

Press Announcement

Pharma Holding

More Later

217

This is a direct paste of some of the "press announcements" made by Pharma Holding.

Should there be any errors, please advise me by e. mail.

This page and others here document much of the history of Ed Klapp and his "company" Pharma Holdings. He is currently on trial for FRAUD. The SEC is prosecuting him in Miami.

Be warned that there appear to be at least two US firms currently approaching Pharma shareholders requesting photocopies of share certificates. One claims to be acting for "a new owner" of Pharma who is winding it up. There is supposed to be $5million to distribute to shareholders. Bearing in mind they are the Last to be compensated in such a bankruptcy case, this seems highly unlikely.

What such a firm can do with photocopied certificates I'm not sure. However it is VERY likely that the approach will next ask for fees, taxes etc which you will NEVER see again. Do NOT be duped!

IMHO

There appears to be some sense of responsibility emerging here.

Nov 2006

WARNING TO OUR SHAREHOLDERS.

This is a further stage in a probable offshore scam. You pay out MORE cash!

We have been advised by several shareholders that they have been contacted by people claiming to represent a brokerage firm in the far east and offering to buy their Pharma Stock as partial payment for the purchase of gold, platinum, etc. In addition to the credit they ascribe to the value of the Pharma stock, those solicited would have to make up the balance in cash.

We gave no knowledge as to how anyone receives a list of our shareholders and are unable to verify the bona fides of such transactions. Accordingly, we strongly urge that stockholders receiving such a notice before making an investment decision review same with their attorneys, accountants, and or their financial advisors as to both the legality and the financial aspects relating thereto.

Nov 9th 2006

PHARMA HOLDINGS ENGAGES BANKING FIRM BATHGATE CAPITAL PARTNERS

Bathgate Partners Website.

November 9, 2006 – Pharma Holdings Incorporated (PHI) has engaged BATHGATE CAPITAL PARTNERS on a non-exclusive basis as its investment banking firm.

Bathgate Capital Partners (www.bathgatepartners.com) was founded in 1995, and has become a preeminent niche investment banking firm serving the microcap corporate market. Bathgate Capital Partners seeks out quality, high-growth companies in order to establish long-term financing relationships and the structuring of mergers, acquisitions and public offerings. Bathgate Capital Partners has represented more than 100 transactions totaling more than $400 million in capital raised for its clients. Through this Agreement, Bathgate Capital Partners will work with Pharma Holdings to make introductions to strategic alliance partners, locate new sales distribution channels and seek various financing alternatives. Pharma Holdings will be represented by Mr. Lee Skoblow of Bathgate Capital Partners who will be responsible for account management and supervision.

According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this Agreement prepares our company to create substantial shareholder value and launch us into the next decade. We are thrilled to make this announcement and look forward to a long, prosperous relationship with Bathgate Capital Partners”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings specializes in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries. Pharma Holdings plans to expand their businesses and seek strategic alliances with other related companies. The relationship with Bathgate Capital will enable this growth and expansion to become a reality according to Mr. Klapp.

January 4, 2007

PHARMA HOLDINGS RESIGNS BATHGATE CAPITAL PARTNERS

Pharma Holdings Incorporated has terminated their engagement with Bathgate Capital Partners as their non-exclusive investment banking firm effective January 1, 2007.

According to Mr. Edward Klapp, President & CEO, Pharma Holdings, the decision was based on a “differences” with the direction the company has decided to take as it’s future course of action. However, Mr. Klapp contends they are still pursuing a public offering and will seek out a new investment banking partner to lead the company in that direction.

Pharma Holdings has retained R. L. Cook CPA’s to prepare a complete audit of the corporate financials in preparation for an IPO offering. The audit is expected to be completed by January 15th, and will be published on the company website at that time. Mr. Klapp expects a record year for sales revenues and expects that Pharma Holdings will continue to grow with some major contracts and announcements still to come.

January 22, 2007

PHARMA HOLDINGS ENGAGES BANKING FIRM SHB CAPITAL

PRESS RELEASE

For Immediate Release: Also verified by SHB.

Pharma Holdings Incorporated (PHI) has engaged SHB CAPITAL, INCORPORATED on a non-exclusive basis as its investment banking firm. investment banking firm. SHB Capital Incorporated (www.SHBCapital.com) is one of the premier investment banking and corporate finance specialists in the United States. SHB specializes in the small business segment of the market and is well-qualified to lead Pharma to the next level of growth we anticipate over the next four years. SHB Capital will offer PHARMA an entire spectrum of services needed to successfully list our company with one of the major exchanges. These services include the establishment of a valuation model to correctly price Pharma, and assistance with the review and correction process to bring all of our corporate documents to public listing standards.

According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this Agreement prepares our company to create substantial shareholder value and launch us into the next decade. We are thrilled to make this announcement and look forward to a long, prosperous relationship with SHB Capital”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings is specialized in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries.

According to Mr. Klapp, this relationship with SHB Capital provides a one-stop business solution that will enable us to focus on growing the company while having access to financing to make new acquisitions. The relationship with SHB Capital will “foster this growth and expansion to become a reality”, according to Mr. Klapp.

PRESS RELEASE

For Immediate Release:

January 22, 2007

MED RX Supply to distribute newly FDA-approved RADIESSE cosmetic dermal filler

Pharma Holdings subsidiary Med-RX Supply has entered into a distribution sales agreement with CPI to distribute the newly FDA-approved cosmetic filler, RADIESSE.

Radiesse, although approved worldwide for many years, has just received FDA approval in the USA as of December 27,2006. Radisees is the next-generation cosmetic dermal filler for long lasting correction of moderate to severe facial wrinkles and folds. Radiesse also received a second FDA approval for the long-lasting correction of facial fat loss (lipoatrophy) in people with HIV virus. It¹s the only product of its kind to receive two separate FDA approvals in the USA. The approval of Radiesses ushers in a new era in the non-surgical management of facial aging because it both volumizes facial folds and rebuilds the skin¹s foundation to restore a youthful facial appearance for patients.

Med-RX plans to market RADIESSE to the specialized plastic surgery market which includes surgeons, dermatologists and industry professionals. throughout the world. Additionally, Med-RX plans to initiate several forms of media including direct mail, space advertising and telemarketing to sell the products worldwide. With more than 25 years experience in the direct marketing and advertising industry, Mr. Edward Klapp, CEO, Pharma Holdings has a successful track-record marketing products on a business-to-business and direct-to-consumer basis.

According to Mr. Klapp, Med-RX will begin marketing this product immediately through the CanadianDrugOutletStore.com website. Mr. Klapp expects to sell more than $100,000 in inventory per month within the first six months and plans for sales to exceed $10 million in the first year of sales on these products.

Currently, Med-RX supply will limit its sales to the Internet and Canada, but plans to expand as the business grows.

Trading Site

This is the online store subsidiary. CanadianDrugOutletStore.

Has anyone used this site?

I am searching for links to the other two.

Nov 14 2006

PHARMA HOLDINGS SIGNS AXCESS MEDICAL AS NATIONAL DISTRIBUTOR

Release

November 14, 2006 – Pharma Holdings Incorporated (PHI) has engaged AXCESS MEDICAL, LLC on a non-exclusive basis as a medical supply distributor for its line of non-pharmaceutical products.

Axcess Medical has a national sales force with more than 20 years experience in sales and marketing of medical products. Their client list reaches doctors, hospitals, wholesalers and retail outlets across the entire United States. More specifically, Axcess Medical services the orthopedic industry and will allow Pharma Holdings to expand its sales into that specific niche market. Axcess Medical will be working closely with Med-RX Supply, a division of Pharma Holdings to develop new business and service the existing business in that market. Med-RX Supply intends to offer some new products to the marketplace, and Axcess Medical has the client base that will quickly gain sales and distribution for these products.

CEO Comments

According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this Agreement is the first step towards expanding our presence in the US market and will provide credibility and awareness of our company in a short period of time”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings specializes in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries. Pharma Holdings expects this relationship will produce sales of $5mm in the first year.

Pharma Holdings plans to expand their businesses and seek strategic alliances with other related companies. The company is also acquiring distribution agreements with medical manufacturing companies that are looking for presence in the US markets. According to Mr. Klapp, the relationship with Axcess Medical will quickly expand to cover a wide array of proprietary products that will be in high demand in the US market.

Comment

Site webmaster comment. How about some information on this partner company?

Nov 16 2006

MED –RX Supply to signs distribution agreement with CANADA MEDICAL SOLUTIONS

Is there a web site for this subsidiary?

November 16, 2006 – Pharma Holdings’ subsidiary Med-RX Supply has entered into a distribution sales agreement with Canada Medical Solutions to market specialty pharmacy medications on their behalf.

Canada Medical Solutions specializes in the sales and marketing of specialty pharmacy medications dealing in the areas of Neurology, Oncology, Orthopedics, Infectious Disease and Cosmetic injectables. Many of these medications are very difficult to locate and are considered hard-to-find products on a global basis.

Med-RX plans to market these items to doctors, clinics, hospitals and urgent care center throughout the world. Additionally, Med-RX plans to initiate several forms of media including direct mail, space advertising and telemarketing to sell the products worldwide. With more than 25 years experience in the direct marketing and advertising industry, Mr. Edward Klapp, CEO, Pharma Holdings has a successful track-record marketing products on a business-to-business and direct-to-consumer basis.

Immediate cash earnings suggested!

According to Mr. Klapp, Med-RX will begin marketing these product immediately through the CanadianDrugOutletStore.com website. Mr. Klapp expects to sell more than $100,000 in inventory per month within the first six months and plans for sales to exceed $10 million in the first year of sales on these products.

Currently, Med-RX supply will limit its sales to the Internet and Canada, but plans to expand as the business grows.

Truth?

Was there ever a link with MacKesson? See early "news" post.

Untruth!

Is the deleted "news" (re Supposed deal with Seikagaku Corporation. This leads to a link to an Adobe pdf file. The actual news entry at Pharma has already been removed.) the only other fraudulent statement?

Page set up November 9th. 2006 Edit October 25th 2011 12.10 BST

January 22, 2007	PHARMA HOLDINGS ENGAGES BANKING FIRM SHB CAPITAL
PRESS RELEASE For Immediate Release: Also verified by SHB.	Pharma Holdings Incorporated (PHI) has engaged SHB CAPITAL, INCORPORATED on a non-exclusive basis as its investment banking firm. investment banking firm. SHB Capital Incorporated (www.SHBCapital.com) is one of the premier investment banking and corporate finance specialists in the United States. SHB specializes in the small business segment of the market and is well-qualified to lead Pharma to the next level of growth we anticipate over the next four years. SHB Capital will offer PHARMA an entire spectrum of services needed to successfully list our company with one of the major exchanges. These services include the establishment of a valuation model to correctly price Pharma, and assistance with the review and correction process to bring all of our corporate documents to public listing standards.
	According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this Agreement prepares our company to create substantial shareholder value and launch us into the next decade. We are thrilled to make this announcement and look forward to a long, prosperous relationship with SHB Capital”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings is specialized in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries.
	According to Mr. Klapp, this relationship with SHB Capital provides a one-stop business solution that will enable us to focus on growing the company while having access to financing to make new acquisitions. The relationship with SHB Capital will “foster this growth and expansion to become a reality”, according to Mr. Klapp.

Trading Site	This is the online store subsidiary. CanadianDrugOutletStore.
Has anyone used this site?	I am searching for links to the other two.

Nov 14 2006	PHARMA HOLDINGS SIGNS AXCESS MEDICAL AS NATIONAL DISTRIBUTOR
Release	November 14, 2006 – Pharma Holdings Incorporated (PHI) has engaged AXCESS MEDICAL, LLC on a non-exclusive basis as a medical supply distributor for its line of non-pharmaceutical products. Axcess Medical has a national sales force with more than 20 years experience in sales and marketing of medical products. Their client list reaches doctors, hospitals, wholesalers and retail outlets across the entire United States. More specifically, Axcess Medical services the orthopedic industry and will allow Pharma Holdings to expand its sales into that specific niche market. Axcess Medical will be working closely with Med-RX Supply, a division of Pharma Holdings to develop new business and service the existing business in that market. Med-RX Supply intends to offer some new products to the marketplace, and Axcess Medical has the client base that will quickly gain sales and distribution for these products.
CEO Comments	According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this Agreement is the first step towards expanding our presence in the US market and will provide credibility and awareness of our company in a short period of time”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings specializes in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries. Pharma Holdings expects this relationship will produce sales of $5mm in the first year.
	Pharma Holdings plans to expand their businesses and seek strategic alliances with other related companies. The company is also acquiring distribution agreements with medical manufacturing companies that are looking for presence in the US markets. According to Mr. Klapp, the relationship with Axcess Medical will quickly expand to cover a wide array of proprietary products that will be in high demand in the US market.
Comment	Site webmaster comment. How about some information on this partner company?

Truth?	Was there ever a link with MacKesson? See early "news" post.
Untruth!	Is the deleted "news" (re Supposed deal with Seikagaku Corporation. This leads to a link to an Adobe pdf file. The actual news entry at Pharma has already been removed.) the only other fraudulent statement?